Loading company…
Xi'an Medisotope Technology develops and produces medical isotopes for diagnosis and treatment.
Founded in 2019 by Quanshi Zhang, Xi'an Medisotope Technology researches, develops and produces medical isotopes, including Actinium-225, Lead-212, Copper-67, Scandium-47 and Molybdenum-99. Its products are used in diagnosing and treating cancer, heart disease and neurological disorders. The company is based in Xianyang, China, and has partnerships with research and nuclear institutions. In August 2026, it raised Pre-Series A funding from China Reform Holdings for site construction, equipment, R&D and operations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in